1st Edition

Medical Affairs The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries

Edited By Kirk V. Shepard, Charlotte Kremer, Garth Sundem Copyright 2024
266 Pages 113 Color Illustrations
by CRC Press

266 Pages 113 Color Illustrations
by CRC Press

266 Pages 113 Color Illustrations
by CRC Press

Medical Affairs is one of the three strategic pillars of the pharmaceutical and MedTech industries, but while clear career paths exist for Commercial and Research and Development, there is no formal training structure for Medical Affairs professionals. Medical and scientific expertise is a prerequisite for entry into the function, and many people transitioning into Medical Affairs have advanced... Read more

SECTION 1: MEDICAL AFFAIRS IN THE PHARMACEUTICAL AND MEDTECH INDUSTRIES

Chapter 1 What Is Medical Affairs?

Kirk Shepard, Charlotte Kremer, Robin Winter-Sperry, Danie du Plessis and Peter Piliero

Chapter 2 Groups and Structure of Medical Affairs

Victoria Elegant, Greta James-Chatgilaou, Darryl Sleep and Bagrat Lalayan

Chapter 3 Medical Affairs Collaborations Across the Drug/Device Development Lifecycle

Tamas Koncz, Gail Cawkwell and Liviu Niculescu

Chapter 4 Measuring the Impact of Medical Affairs

Anna Walz, Paul Tebbey, Jovanka Paunovich and Joe Kohles

Chapter 5 Medical Affairs Careers

Peter Piliero, Jim Alexander, Danny McBryan, Patrick Reilly, Wendy Fraser and Charlotte Raabe-Hielscher

SECTION 2: THE PRACTICE OF MEDICAL AFFAIRS

Chapter 6 Medical Strategy and Launch Excellence

Meg Heim, Rachele Berria, Loubna Bouarfa, Deb Braccia, Shontelle Dodson, Andrew Greenspan, Deborah Long, Ameet Nathwani, Tam Nguyen, Holly Schachner, Roz Schneider, Ajay Tiku, Rebecca Goldstein and Stephanie Wei

Chapter 7 Evidence Generation and Real-World Evidence

Ann Hartry, Charlotte Kremer, Judith Nelissen, Omar Dabbous, Suzanne Giordano and Kristine Healey

Chapter 8 Medical Communications

Renu Juneja, Rob Mattheis, Sandrine Jabouin and Noreen Hussein

Chapter 9 External Education  

Shontelle Dodson, Kirtida Pandya, Marleen van der Voort, Maureen Doyle-Scharff and Kimberly Braithwaite

Chapter 10 Field Medical

Robin Winter-Sperry, Kathy Gann, Suzanne Giordano, Lori Mouser and Rich Swank

Chapter 11 Insights

Sandra Silvestri, Siobhan Mitchell, Dr Mónica de Abadal, Catrinel Galateanu and Monique Furlan

Chapter 12 Medical Information

Evelyn R. Hermes-DeSantis, Stacey Fung, Kristin Goettner, Christopher J. Keenan, Marie-Ange Noue and Jill Voss

Chapter 13 Patient Centricity

Danie du Plessis, Oleks Gorbenko, Isabelle Bocher-Pianka, Tricia Gooljarsingh, Karen King and Roslyn F. Schneider

Chapter 14 Medical Operations

Suzana Giffin, Bjorn Oddens, George Betts, Søren Buur, Arnaud Gatignol and Sokhon Bouy

Chapter 15 Digital Strategy

Rishi Ohri, Sarah Clark and Richard Kemper

Chapter 16 Compliance

Maureen J. Lloyd and Jessica Santos

Chapter 17 Rare Disease & Gene Therapy

Nikolai Nikolov, Leonard A Valentino and Tricia Gooljarsingh

Chapter 18 Medical Affairs in MedTech

William Sigmund, John Pracyk, Tobi Karchmer, Joao D. Dias, Klaus Hoerauf, Idal Beer, David Macarios, Bill Altonaga, Greg Christopherson, Ann Ford, Dee Khuntia, Sean Lilienfeld, Mark Miller, Hany Moselhi, Ross "Rusty" Segan and Ronald Silverman

Biography

Medical Affairs Professional Society

MAPS is the premier non-profit global Medical Affairs organization FOR Medical Affairs professionals BY Medical Affairs professionals across all different levels of experience/specialty to engage, empower and educate. Together with over 9,000 Medical Affairs members from 280+ companies globally, MAPS is transforming the Medical Affairs profession to increase its value to patients, HCPs and other decision makers.

Dr. Kirk Shepard has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs OBG at Eisai Pharmaceutical Company. Dr. Shepard’s experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE). Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books. Dr. Shepard earned his bachelor’s degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.

Charlotte M. E. Kremer, MD, MBA is formerly the Executive VP and Head of Medical Affairs for Astellas, recently retired. In this role, Dr. Kremer provided leadership for the Medical Affairs organization globally. Dr. Kremer joined Astellas in 2012 with 20 years of experience in the pharmaceutical industry. Prior to Astellas, she held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical programs in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase 3b/4 clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States. A native of the Netherlands, Dr. Kremer received her medical degree from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.

Garth Sundem is Director of Communications & Marketing with the Medical Affairs Professional Society (MAPS). Previously, he was Science Writer and then Communications Manager for the University of Colorado Cancer Center, writing more than 500 articles on topics ranging from basic science to cancer survivorship. Garth has written and ghostwritten more than a dozen mass-market books for publishers including Crown, Three Rivers, Ben Bella, Workman Publishing and Free Spirit Press, on topics including math humor, pop science, and psychology (full list at Amazon). He has been featured on Good Morning America, NPR, CBS, BBC and the Discovery Channel (among others), has written for outlets including the New York Times, WIRED, Scientific American, Sky & Telescope and Men’s Health (among others), and was a core contributor at sites including GeekDad.com and PsychologyToday.com. He graduated summa cum laude from Cornell University.